Efficacy of biologics and targeted synthetic disease-modifying antirheumatic drugs approved in the Russian Federation to treat adults with active rheumatoid arthritis: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy of biologics and targeted synthetic disease-modifying antirheumatic drugs approved in the Russian Federation to treat adults with active rheumatoid arthritis: a systematic review and network meta-analysis

Published:2022 Issue:1 Volume: Page:50
ISSN:2219-0678
Container-title:Medical Technologies. Assessment and Choice
language:en
Short-container-title:Med. Tech. Asses. and Choice

Author:

Sokolova V.D.^ORCID,Mladov V.V.^ORCID,Sableva N.A.^ORCID,Tolkacheva D.G.^ORCID

Publisher

Media Sphere Publishing Group

Subject

General Medicine

Reference34 articles.

1. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis

2. Prevalence of rheumatic diseases in Russia

3. Assessment of organization of medical care and drug provision for patients with rheumatic diseases, and the socioeconomic burden of these diseases in the Russian Federation

4. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

5. Revmatoidnyj artrit. Klinicheskie rekomendatsii. Assotsiatsiya revmatologov Rossii, OOOI «Rossijskaya revmatologicheskaya assotsiatsiya «Nadezhda»; 2021. Accessed September 01, 2021. (In Russ.). @@https://cr.minzdrav.gov.ru/recomend/250_2

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP